Chuanbin Wu
Impact in
- Pharmaceutical Science top 0.01%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 0.2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advancements in Transdermal Drug Delivery 90
- Advanced Drug Delivery Systems 75
- Drug Solubulity and Delivery Systems 59
-
- RNA Interference and Gene Delivery 37
- Co-authors
- Xin Pan (210 shared papers)Guilan Quan (92 shared papers)Yixian Zhou (24 shared papers)Boyi Niu (18 shared papers)Ying Huang (94 shared papers)Ting Wen (19 shared papers)Chao Lü (53 shared papers)Zhengwei Huang (89 shared papers)
- Journals
- International Journal of Pharmaceutics (36 papers)AAPS PharmSciTech (19 papers)Acta Pharmaceutica Sinica B (18 papers)Journal of Controlled Release (17 papers)Pharmaceutics (12 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Chuanbin Wu
365 papers receiving 13.0k citations
Chuanbin Wu's Hit Papers
Peers
Comparison fields: 5 of 174
- Pharmaceutical Science 4.7k
- Biomaterials 2.2k
- Dermatology 1.3k
- Molecular Medicine 448
- Microbiology 460
Countries citing papers authored by Chuanbin Wu
This map shows the geographic impact of Chuanbin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuanbin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuanbin Wu more than expected).
Fields of papers citing papers by Chuanbin Wu
This network shows the impact of papers produced by Chuanbin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuanbin Wu. The network helps show where Chuanbin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chuanbin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 378 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy Hit paper breakdown → | 2021 | 854 |
| 2 | Mesoporous silica nanoparticles for drug and gene delivery Hit paper breakdown → | 2018 | 542 |
| 3 | 2005 | 234 | |
| 4 | 2004 | 209 | |
| 5 | 2020 | 188 | |
| 6 | 2014 | 172 | |
| 7 | 2011 | 150 | |
| 8 | 2003 | 150 | |
| 9 | 2016 | 143 | |
| 10 | 1988 | 137 | |
| 11 | 2016 | 135 | |
| 12 | 2019 | 133 | |
| 13 | 2007 | 133 | |
| 14 | 2018 | 127 | |
| 15 | 1999 | 125 | |
| 16 | 2021 | 123 | |
| 17 | 2021 | 122 | |
| 18 | 2017 | 117 | |
| 19 | 2011 | 111 | |
| 20 | 2008 | 109 |
About Chuanbin Wu
Chuanbin Wu is a scholar working on Pharmaceutical Science, Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering and Biomaterials, having authored 378 papers that have together received 13.2k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (90 papers), Advanced Drug Delivery Systems (75 papers), Drug Solubulity and Delivery Systems (59 papers), Inhalation and Respiratory Drug Delivery (47 papers), Nanoplatforms for cancer theranostics (39 papers), Nanoparticle-Based Drug Delivery (38 papers), RNA Interference and Gene Delivery (37 papers) and Dermatology and Skin Diseases (27 papers). The work is most often cited by research in Pharmaceutical Science (4.7k citations), Biomaterials (2.2k citations), Dermatology (1.3k citations), Molecular Medicine (448 citations) and Microbiology (460 citations). Chuanbin Wu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xin Pan, Guilan Quan, Yixian Zhou, Boyi Niu, Ying Huang, Ting Wen, Chao Lü, Zhengwei Huang, Yuehong Xu and Kaixin Liao. Their work appears in journals such as International Journal of Pharmaceutics, AAPS PharmSciTech, Acta Pharmaceutica Sinica B, Journal of Controlled Release and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.